Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements
07. November 2024 09:09 ET
|
Biomerica, Inc.
IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day...
Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16
10. November 2023 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products today announced that it will participate in the 14th...
Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022
13. Oktober 2022 16:50 ET
|
Biomerica, Inc.
Notice of Patent Allowance in Australia containing broad claims pertaining to treating ADD/ADHD using the InFoods® Technology Notice of Patent Allowance in Japan containing broad claims pertaining to...
Biomerica Reports Fiscal 2022 Year End Results
29. August 2022 16:41 ET
|
Biomerica, Inc.
Revenues increase 162% for fiscal 2022 vs fiscal 2021 Revenues for fiscal Q4 2022 up 403% vs. fiscal Q4 2021 IRVINE, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the...
Biomerica to Participate at BTIG Biotech Conference
23. Juni 2022 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., June 23, 2022 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that the Company’s CEO will participate at the 2022 BTIG Biotechnology Conference being held in person...
Biomerica Announces Filing of New Three Year Shelf Registration Statement
22. Juli 2020 06:39 ET
|
Biomerica, Inc.
IRVINE, Calif., July 22, 2020 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that it has filed a new three year shelf registration statement on Form S-3 with the United States...